SCHEMBL1077138

SCHEMBL1077138

O=S(=O)(Cl)c1cccc2[nH]ncc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.55
JAK2 O60674 1/20 0.51
JAK1 P23458 1/20 0.51
AXL P30530 2/20 0.50
IDO1 P14902 3/20 0.47
METAP2 P50579 1/20 0.46
ALDH1A1 P00352 1/20 0.43
DHPS P49366 1/20 0.40
GAA P10253 1/20 0.39
BRAF P15056 1/20 0.39
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
HSP90AA1 P07900 1/20 0.38
CDK2 P24941 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28808758 0.85 JAK2 (0.54) NOS1JAK2JAK1AXLIDO1
SCHEMBL20789987 0.82 NOS1 (0.55) NOS1JAK2JAK1AXLIDO1
Hydrochloric Acid SCHEMBL28295355 0.81 JAK2 (0.50) NOS1JAK2JAK1AXLIDO1
SCHEMBL21903867 0.79 ALDH1A1 (0.47) NOS1JAK2JAK1ALDH1A1LMNA
SCHEMBL574814 0.76 METAP2 (0.55) NOS1JAK2JAK1AXLIDO1
SCHEMBL30689208 0.71 NOS1 (0.55) NOS1IDO1ALDH1A1CYP1A2CYP3A4
SCHEMBL29904571 0.71 CDK2 (0.46) ALDH1A1CYP1A2CYP3A4CYP2C19HTT
SCHEMBL3133065 0.71 CDK2 (0.46) ALDH1A1CYP1A2CYP3A4CYP2C19HTT
SCHEMBL4314318 0.71 NOS1 (1.00) NOS1JAK2JAK1AXLIDO1
SCHEMBL476854 0.71 NOS1 (1.00) NOS1JAK2JAK1AXLIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109790122-A Heterocyclic compound 武田药品工业株式会社 2019-05-21 CN disclosed
EP-2276731-A1 2-SULFONYLAMINO-4-HETEROARYL BUTYRAMIDE ANTAGONISTS OF CCR10 Boehringer Ingelheim International GmbH (DE) 2011-01-26 EP disclosed
WO-2009126675-A1 2-SULFONYLAMINO-4-HETEROARYL BUTYRAMIDE ANTAGONISTS OF CCR10 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 WO disclosed